AperçuGraphiqueActualitésTraderScreen

DZ Bank Aktienanleihe SIX2 27.09..../  DE000DJ49DY1  /

Frankfurt Zert./DZB
23/05/2024  21:34:38 Chg.-1.570 Bid21:59:40 Demandez à21:59:40 Sous-jacent Prix d'exercice Date d'expiration Type d'option
84.570EUR -1.82% 84.560
Bid taille: 50,000		 86.060
Ask la taille: 50,000		 SIXT SE ST O.N. 90.00 EUR 27/09/2024 Call
GlobeNewswire 23:01 Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...
GlobeNewswire 23:01 Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire 23:01 HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical...
GlobeNewswire 23:00 Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Co...
TeleTrader 23:00 Iran-backed militia claims drone attack on Eilat
GlobeNewswire 23:00 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term E...
GlobeNewswire 23:00 Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire 23:00 Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
GlobeNewswire 23:00 MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBIN...
GlobeNewswire 23:00 Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m...
GlobeNewswire 23:00 Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire 23:00 Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire 23:00 NVIDIA Announces Upcoming Event for Financial Community
GlobeNewswire 23:00 Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...
GlobeNewswire 23:00 Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology A...
GlobeNewswire 23:00 Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monothera...
GlobeNewswire 23:00 IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2...
GlobeNewswire 23:00 Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 ...
GlobeNewswire 23:00 Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head a...
GlobeNewswire 23:00 Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at ...
GlobeNewswire 22:55 Park Aerospace Corp. Announces Date of Fiscal Year Earnings Release and Conference Call
GlobeNewswire 22:49 THOR Industries Announces Date For Its Fiscal 2024 Third Quarter Earnings Release
GlobeNewswire 22:46 Acme United Corporation Acquires the Assets of Elite First Aid
GlobeNewswire 22:45 ValueZone Strengthens Resources for Traders in Current Bull Market
GlobeNewswire 22:45 Inari Medical, Inc. (NARI) Investors: July 12, 2024 Filing Deadline in Securities Class Action - Con...